patients reversed with neostigmine or sugammadex or in cases where reversal was considered unnecessary (spontaneous recovery). The secondary objectives were to evaluate the following variables: the oxygen saturation (SpO 2 ) upon PACU arrival, episodes of SpO 2 <90% in the PACU, airway manoeuvres and/or stimulation required to maintain SpO 2 >90% in the PACU and the need for re-intubation.
MATERIALS AND METhODS

Study design
This was an observational, non-interventional and non-randomised study that involved adult patients undergoing different types of elective surgical procedures that required general anaesthesia with NMBDs and it reflected routine clinical practice. The anaesthetic technique and management of neuromuscular block in the operating room were conducted at the discretion of the anaesthesiologist and performed in accordance with our standard clinical practice. No interventions were scheduled other than those required for routine patient care.
Approximately 600 patients who were to receive NMBDs for elective surgical procedures were prospectively and successively enrolled in our study. This number approximated the number of patients included in a similar study performed in our department six years previously 12 . The inclusion criteria were as follows: 18 years of age or older, admission for non-emergency surgery, signed informed consent and NMBD administration during surgery requiring tracheal intubation. Subjects were excluded from the study if they did not fulfil the inclusion criteria or in the following cases: evidence of renal, hepatic, metabolic and/or neuromuscular disorders; ejection fraction <20%; admission for cardiac surgery; or reoperation during the same hospital admission. This study was approved by the local ethics committee (approval number 2011/019). The study was conducted under close supervision of the principal investigator and author, G. Cammu, and assistance was provided by a qualified research nurse with TOF-Watch ® (Organon Ireland Ltd, a division of MSD, Swords, Co., Dublin, Ireland) experience. The anaesthesiologists involved were aware that a study was being performed on PORC, which may have been a source of bias. however, in an attempt to overcome this type of bias, the study took place only two to three days a week and the order of study days differed each week.
Study flowchart
Upon arrival in the PACU, all subjects received oxygen at 3 l/minute through a nasal cannula. The baseline oxygen saturation values were recorded one minute after application. Immediately after the patients' arrival in the PACU, a study nurse recorded the tympanic temperatures and acceleromyographic responses of the adductor pollicis muscle (as the TOF%) upon TOF-Watch stimulation of the ulnar nerve. The stimulus current was set in the range of 25 to 35 mA for the purpose of tolerance 13 . Two consecutive TOF measurements (separated by 15 seconds) were obtained, and the average of the two values was recorded. If measurements differed by >10%, additional TOF measurements were obtained (up to four TOF values) and the closest two ratios were averaged. A TOF of 90% was used as the cutoff value to exclude PORC. Pulse oximetry was measured continuously throughout the PACU admission and the SpO 2 values were recorded at one-minute intervals for the first 30 minutes. The PACU nurses caring for the patient documented the following events during the first 30 minutes of PACU admission: episodes of hypoxaemia (SpO 2 <90%); the lowest SpO 2 observed; the requirement for either tactile or verbal stimulation to maintain SpO 2 >90%; and any clinical evidence of airway obstruction that required an airway manoeuvre (such as head-tilt, chin-lift or jaw-thrust manoeuvres; placement of a nasal or oral airway; or eventually, re-intubation).
The following baseline variables were registered: the patients' physical characteristics, the American Society of Anesthesiologists Physical Status (ASA PS) class, possible preoperative treatment for cardiac and/or pulmonary disease (regular oral drug intake for systemic hypertension or atrial fibrillation, therapy with diuretics, inhaled b 2 agonists or anticholinergic drugs, inhaled steroids or other agents) and the type of surgical procedure. We noted whether aminoglycosides or magnesium were administered perioperatively, which maintenance anaesthetic technique was used (total intravenous or inhalational anaesthesia) and which NMBD was used intraoperatively (succinylcholine, atracurium, cisatracurium, mivacurium and rocuronium are the NMBDs available at our institution). We recorded the NMBD intubating dose, the repeat doses and their times of administration, the duration of anaesthesia and the time from the last NMBD injection to arrival in the PACU. The total NMBD dose was expressed as the 95% effective dose per hour (ED 95 /hour). We recorded whether neuromuscular transmission monitoring was used before extubation of the trachea in the operating room and in cases where it was used, what the TOF count was at the end-of-surgery (0-1-2-3-4 with visual/tactile fade-4 without visual/tactile fade). (In our department, anaesthesiologists tend to use qualitative instead of quantitative neuromuscular transmission monitoring.) We noted whether extubation in the operating room was based on anticipated spontaneous recovery or pharmacological reversal (with neostigmine or sugammadex) and the length-of-stay in the PACU. The research nurse did not collect intraoperative patient data until at least after the TOF data were recorded in the PACU.
Statistical analysis
Power and sample size For the power analysis, we refer to a study by Murphy and colleagues in which 19/90 (21.1%) subjects had episodes of hypoxaemia (SpO 2 <90%) during PACU admission (in a conventional TOF group) 10 . None of the patients in the acceleromyographicallymonitored group exhibited SpO 2 <90% during PACU admission. This result could be expected with sugammadex, since none of the sugammadextreated patients had an SpO 2 <90% during PACU admission. Group sample sizes of 42 in group one (a sugammadex treatment group) and 42 in group two (a control group without sugammadex treatment) achieved a 90% power to detect a difference of -0.211 in the group proportions. The proportion in group one was assumed to be 0.211 under the null hypothesis and zero under the alternative hypothesis. The proportion in group two was 0.211. The statistical test used was the two-sided Fisher's exact test. The significance level of the test was targeted at 0.05. The significance level actually achieved by this design was 0.029. At least 42 patients receiving sugammadex for reversal would be required to demonstrate statistically significant differences in the number of subjects with SpO 2 <90% during PACU admission who were reversed with sugammadex or not (neostigmine or spontaneous recovery).
Statistical methods
The applied statistical software was SAS Version 9.2 (SAS Institute Inc., Cary, NC, USA). All continuous variables were summarised overall and/ or according to the subgroups (patients with a TOF ≥90% or <90% in the PACU, patients reversed with neostigmine or sugammadex and patients who were not reversed). The descriptive statistics included the number of observations, mean and standard deviation (SD). All of the categorical variables were also summarised overall and/or according to the subgroups. The descriptive statistical summaries included the absolute frequencies and percentages of the overall results, as well as the relative frequencies and percentages of the subgroups. To assess potential significant differences between the subgroups for continuous variables, parametric or non-parametric statistical tests (Student's t-test and Wilcoxon signed-rank test) were applied, depending on whether the data were normally distributed. To assess the potential significant differences between the subgroups for categorical variables, contingency tables were generated and appropriate statistical tests, such as Pearson's chi-square test or Fisher's exact test, were applied. When multiple comparisons were performed, the one-way analysis of variance (ANOVA) was used and Bonferroni's correction was applied to the significance level. All tests were twotailed and P <0.05 was considered significant.
Multivariate analyses
A logistic regression model was used to assess the independent variables that contributed to the effect on the dependent variable, i.e. the incidence of PORC, as defined by a TOF <90% upon PACU arrival. We included the following variables as possible independent or explanatory variables: age, gender, body mass index (BMI), ASA PS class, preoperative treatment for cardiac disease, preoperative treatment for pulmonary disease, type of surgery, type and total dosing of NMBD, the absence of neuromuscular monitoring before extubation, the absence of pharmacological reversal before extubation, the duration of anaesthesia, the body temperature upon PACU arrival and the time from the last NMBD administration to the time of TOF recording in the PACU. Independent or explanatory variables with P <0.05 were included in the model. Additionally, a logistic regression model was proposed to assess which independent variables contributed to the effect of another dependent variable, namely, the number of patients with episodes of SpO 2 <90% in the PACU. In this case, the potential independent or explanatory variables were as follows: age, gender, body mass index (BMI), ASA PS class, preoperative treatment for cardiac disease, preoperative treatment for pulmonary disease, type of surgery, type of anaesthesia (inhalational or total intravenous anaesthesia), type and total dosing of NMBD, duration of anaesthesia, body temperature upon PACU arrival, a TOF <90% upon PACU arrival and the time from the last NMBD administration to the TOF recording in the PACU. Independent or explanatory variables that exhibited P <0.05 were included in the model. 
RESULTS
Patients
In total, 624 patients were included. The dropout rate for this study was zero. The patients had typically undergone ear, nose and throat (ENT)/maxillofacial/ dental surgery, vascular surgery or neurosurgery of the spine. Nearly half of the studied patients were ASA PS class II (Table 1) . No magnesium or aminoglycosides were administered perioperatively; only two (0.3%) patients received maintenance anaesthesia without inhalational anaesthetics and instead received total intravenous anaesthesia.
NMBD management
Extubation in the operating room was based on anticipated spontaneous recovery in 441 (71%) patients. The anaesthesiologists defined spontaneous recovery based on clinical appraisal or a TOF count of four without visual/tactile fade at the endof-surgery when neuromuscular monitoring was used (n=167/441, 38%). Pharmacologically reversed patients received neostigmine (n=139) as follows: 12.5 µg/kg (n=1); 20 µg/kg (n=22); 25 µg/kg (n=5); 30 µg/kg (n=59); 35 µg/kg (n=8); 40 µg/kg (n=19); 45 µg/kg (n=1); 50 µg/kg (n=22); 70 µg/kg (n=1); or 80 µg/kg (n=1). Fifty-four (39%) of these 139 patients were reversed with neostigmine without preceding neuromuscular monitoring. In the patients who were reversed with sugammadex (n=44), the antagonist dose was 1 mg/kg in two patients, 2 mg/kg in 32 patients, 3 mg/kg in three patients and 4 mg/kg in seven patients. Forty-one (93%) of the 44 patients reversed with sugammadex received neuromuscular monitoring prior to sugammadex administration. Of the three patients who did not, one received 4 mg/kg and two patients received 2 mg/kg. The TOF count at reversal (neostigmine and sugammadex, n=183) was four in 92 (51%), three in ten (5%), two in ten (5%), one in nine (5%) and zero in five (3%) patients. Among these latter five patients, four were reversed with sugammadex whereas in one case, 40 µg/kg neostigmine was administered, resulting in a TOF of 96% in the PACU. however, in this patient, 47 minutes passed between the discontinuation of the anaesthetics and arrival in the PACU; in the four patients reversed with sugammadex, this time interval was ten minutes (range seven to 19 minutes).
PACU neuromuscular and respiratory monitoring
Overall, 14% (88/624) of the study patients had PORC, i.e. a TOF <90%, in the PACU. Fifteen percent (66/441) of the patients who spontaneously recovered from their neuromuscular block and 15% (21/139) of those antagonised with neostigmine had PORC, compared with 2% (1/44) of patients who received sugammadex for reversal. In 47% (41/88) of the patients with PORC, qualitative neuromuscular monitoring had been used before extubation, as was the case in 47% (252/536) of the patients without PORC. Table 1 shows the preoperative and intraoperative variables and the neuromuscular and respiratory monitoring results and respiratory events in the PACU in patients who recovered spontaneously and patients reversed with neostigmine or sugammadex. None of the studied patients required reintubation in the PACU. No differences were found between the patients with or without PORC in the PACU in terms of the PACU respiratory monitoring results and airway management ( Table 2) .
Determinants of PORC and SpO2 <90% in the PACU
The univariate analysis showed that no variables were associated with PORC (see Appendix 1 in the online version); because we think that there is no compelling reason to maintain insignificant factors in an analysis, logistic regression was not performed. In the univariate analysis, the variables associated with SpO 2 <90% during the PACU stay were age (P=0.0035), BMI (P=0.0012), ASA PS class (P <0.0001), preoperative treatment for cardiac disease (P <0.0001), vascular surgery (P=0.0021) and the time from the last NMBD administration to the TOF recording in the PACU (P=0.018) (see Appendix 2 in the online version). Due to the very small number of patients who underwent thoracic surgery, this variable was not included in the logistic regression. The logistic regression model determined that BMI was the only independent predictor of SpO 2 <90% during the stay in the PACU (Table 3 ).
DISCUSSION
The incidence of PORC after NMBDs strongly decreased in our institution from 39% in 2005 to 14% in 2011 12 . Our study shows that 15% of patients who apparently spontaneously recovered from their neuromuscular block and 15% of those antagonised with neostigmine exhibited PORC in the PACU, as opposed to only 2% of the patients who received sugammadex for reversal. Seventy-one percent of our study population were not pharmacologically reversed before extubation. Patients without reversal received a lower dose of NMBDs and underwent surgeries with longer durations than patients who received neostigmine; this was to be expected because the NMBD was not only administered at a lower dose but also had more time to be eliminated. This result is in line with the findings by Videira et al in which the clinical decision in their institution to antagonise NMBDs seemed mainly based on the pharmacological forecast 14 . Only 38% of the patients not reversed received neuromuscular monitoring prior to tracheal extubation. In those patients reversed with neostigmine, 39% were not monitored before reversal; i.e. they received routine reversal. Moreover, the anaesthesiologists appeared to use a wide variety of neostigmine doses. Nearly all patients treated with sugammadex were monitored before reversal; however, this number may have been driven by the local reimbursement system that requires attestation of the TOF measurement. Most of the patients reversed with sugammadex underwent ENT/ maxillofacial/dental surgery or neurosurgery of the spine. The anaesthesiologists may have preferred sugammadex for these types of surgeries because of their short duration and the lack of muscarinic effects after treatment with sugammadex in ENT/ maxillofacial/dental surgery. Also, the short operating and rapid closing times in spinal neurosurgery may require more profound intraoperative muscle relaxation later into the procedure. Minimally, invasive spine surgery has the issue of rapid closing times and theoretically sugammadex could be an advantage. Thirty-two of the 44 sugammadex-reversed patients received 2 mg/kg sugammadex. In addition, sugammadex doses different from those suggested for the reversal of moderate (2 mg/kg) or profound block (4 mg/kg) were used in this study 15, 16 . As proposed by other authors, a dose less than 2 mg/kg was used for a more shallow block than a TOF count of two (1 mg/kg, n=2) 17 .
In patients with spontaneous recovery, more mivacurium and less rocuronium were used. higher SpO 2 values upon PACU arrival were noted in the spontaneously recovered patients compared with patients who received neostigmine. however, considerably more patients had abdominal surgery in the neostigmine reversal subgroup than in the group of patients who recovered spontaneously. The neuromuscular and respiratory monitoring results, as well as the respiratory events in the PACU, tended to favour the patients reversed with sugammadex compared with the spontaneously recovered patients or those reversed with neostigmine. however, again, patients receiving neostigmine underwent more abdominal procedures, and the number of sugammadex-treated patients was small and the differences were not statistically significant. Moreover, these findings are difficult to explain; although less PORC was encountered after sugammadex than after spontaneous recovery or neostigmine reversal, a TOF <90% upon PACU arrival was not associated with SpO 2 <90% during the PACU stay in this study. It is possible that mechanisms other than the improved TOF results may play a role in the tendency for improved early postoperative respiratory parameters after sugammadex administration. We speculate that a greater portion of the postjunctional acetylcholine receptors are unoccupied after sugammadex reversal than after neostigmine or spontaneous recovery. Some findings of this study seem to contradict findings in the literature. First, we did not find that the absence of neuromuscular monitoring or absence of pharmacological reversal before extubation is associated with PORC 7, 11 . In 53% of our study patients, neuromuscular block remained unmonitored at the end-of-surgery; however, other authors have found that acceleromyography monitoring reduces the incidence of PORC and associated unpleasant symptoms of muscle weakness in the PACU and improves the overall quality of recovery 18 . Second, in contrast with other authors, we found no differences in the PACU respiratory and airway variables between patients with or without PORC 10, 19 . hence, a TOF <90% upon PACU arrival was not associated with a SpO 2 <90% during the PACU stay. In contrast, we found that the BMI was an independent predictor of SpO 2 <90% during the PACU stay. The discrepancy between these findings and those of other reports may be explained by differences in study design or the thresholds used to define hypoxaemia (e.g. SpO 2 <93% versus <90% in our study) 10, 19 . Moreover, our data are in line with recent findings in which no effects of PORC on oxygen saturation on arrival in the PACU or on airway management were observed 20 . In a volunteer study, heier and colleagues found that none of the subjects experienced airway obstruction or arterial oxygen desaturation, even at a normalised TOF ratio of less than 0.4. however, this was not a study of postoperative patients exposed to the additional residual effects of anaesthetics and opioids 21 .
There are limitations to this investigation. First, the data on the incidence of PORC is only observational; no implications can be made because there was no randomisation and there were recognised differences between the groups that may account for the different incidences. however, a randomised trial investigating PORC and the early respiratory outcome would also have limitations because a randomised trial investigating the above questions and assessing rare outcomes (such as postoperative respiratory failure) would likely require many more patients. Moreover, given our study's objectives, ethical objections to randomisation may exist 22 . A second limitation of the current study may be that the TOF-Watch monitor was not calibrated or normalised before NMBD administration. In addition, an isolated measurement at the end of anaesthesia likely underestimates the true incidence of PORC 23 . Moreover, the accuracy of acceleromyography in awake postoperative patients has been questioned 24 . To improve performance and reduce variability during recovery, we performed a series of stimuli rather than obtaining a single TOF ratio in the PACU. Schreiber et al recently observed good agreement in detecting the presence or absence of PORC between calibrated and non-calibrated acceleromyography. however, in their study, a TOF ratio of <1.0, not <0.9, was chosen as the threshold for PORC 25 . A third limitation is that we did not register opioid consumption intra and postoperatively or record the minimum alveolar concentration values of the volatiles administered during anaesthesia. Such data might have been valuable for investigating the determinants of PORC and hypoxaemia. The limited power to assess secondary outcomes must also be considered.
In summary, 15% of the patients who apparently spontaneously recovered from their neuromuscular block and 15% of those antagonised with neostigmine had PORC in the PACU compared with 2% of patients who received sugammadex for reversal. The absence of the use of neuromuscular monitoring and absence of pharmacological reversal before extubation were not found to be associated with PORC. In contrast with the data reported by other studies, TOF <90% upon PACU arrival was not found to be associated with SpO 2 <90% during the PACU stay. Larger series are necessary to explore the impact of PORC and reversal on longer-term respiratory variables and outcome.
